Non-invasive optical probe reveals the complex changes in tumors after immunotherapy
Johns Hopkins University engineers are the first to use a non-invasive optical probe to understand the complex changes in tumors […]
» Read moreHome »
It's a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one […] Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […] An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a […] Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted […] Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted […] A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […] Scientists at The Wistar Institute have created an advanced humanized immune system mouse model that allows them to examine resistance […] University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, […] Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people with cancer respond to the […]
Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer
Adverse Reactions to Immunotherapy Can Appear After a Year
Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
New immunotherapy target discovered for malignant brain tumors
Scientists discover new immunotherapy target for malignant brain tumors
First Drug That Protects Against Chemo-Induced Myelosuppression
New humanized mouse model provides insight into immunotherapy resistance
Why immunotherapy only works for some with head and neck cancer
Study identifies patients with lung cancer most likely to respond to immunotherapy
